Literature DB >> 16340570

Laparoscopic treatment of liver hemangioma.

Alberto Patriti1, Luigina Graziosi, Andrea Sanna, Nino Gullà, Annibale Donini.   

Abstract

Cavernous hemangioma is the most common benign liver tumor. When it becomes symptomatic, enucleation is considered the treatment of choice because of its lower morbidity compared with liver resection. Therefore, although there have been many series of laparoscopic liver resection, only a few cases of laparoscopic enucleation of liver hemangiomas have been reported. We report the case of a 36-year-old woman with a symptomatic 4-cm liver hemangioma of the left lobe who underwent laparoscopic enucleation, with complete relief of the symptoms at the 3-month follow-up. The operating time was 90 minutes. Neither liver mobilization nor ligament division was necessary. The dissection was carried out with minimal blood loss. The postoperative period was uneventful, and the patient was discharged on postoperative day 4. Laparoscopic enucleation is easy to perform in suitable lesions, and its advantage with respect to liver resection is the preservation of healthy parenchyma and liver ligaments. No outflow occlusion is needed, and the intraoperative bleeding is easily controlled. Technical aspects of laparoscopic enucleation are described and a review of the literature is also provided.

Entities:  

Mesh:

Year:  2005        PMID: 16340570     DOI: 10.1097/01.sle.0000191621.47886.74

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

1.  Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments.

Authors:  Luciano Casciola; Alberto Patriti; Graziano Ceccarelli; Alberto Bartoli; Cecilia Ceribelli; Alessandro Spaziani
Journal:  Surg Endosc       Date:  2011-06-08       Impact factor: 4.584

2.  Laparoscopic resection of giant liver hemangioma using laparoscopic Habib probe for parenchymal transection.

Authors:  Srikanth Gadiyaram; Neel Shetty
Journal:  J Minim Access Surg       Date:  2012-04       Impact factor: 1.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.